MARKET

TCMD

TCMD

Tactile Systems
NASDAQ
13.75
-0.30
-2.14%
Opening 11:19 05/10 EDT
OPEN
14.01
PREV CLOSE
14.05
HIGH
14.15
LOW
13.61
VOLUME
40.36K
TURNOVER
0
52 WEEK HIGH
26.11
52 WEEK LOW
9.70
MARKET CAP
326.73M
P/E (TTM)
11.62
1D
5D
1M
3M
1Y
5Y
Tactile Systems: Report of proposed sale of securities
Press release · 2d ago
Oppenheimer Remains a Buy on Tactile Systems Technology (TCMD)
TipRanks · 3d ago
Tactile Systems Technology (TCMD) Gets a Buy from Piper Sandler
TipRanks · 3d ago
TCMD Stock Earnings: Tactile Systems Tech Beats EPS, Beats Revenue for Q1 2024
Tactile Systems Tech reported earnings per share of -5 cents for the first quarter of 2024. The company reported revenue of $61.09 million. This was 3.24% better than the analyst estimate for the same period. Tactile systems tech also reported results for the fourth quarter of 2015.
Investorplace · 4d ago
Tactile Systems Technology, Inc. Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended: March 31, 2024
Press release · 4d ago
Tactile Systems Technology Continues To Expect FY24 Total Revenue Of $300M-$305M, Est $302.9M
Benzinga · 4d ago
Tactile Systems Technology Inc reports results for the quarter ended in March - Earnings Summary
Tactile Systems Technology Inc reports results for the quarter ended in March. The company reported a quarterly adjusted loss of 9 cents per share. Revenue fell 9.4% to $53.31 million from the same quarter last year. The average analyst rating on the shares is "strong buy"
Reuters · 4d ago
Tactile Systems Technology GAAP EPS of -$0.09 misses by $0.01, revenue of $61.1M beats by $1.87M
Tactile Systems Technology, Inc. GAAP EPS of -$0.09 misses by $0.01, revenue of $61.1M beats by $1.87M. Q1 GAAP revenue was up 3.9% from a year ago.
Seeking Alpha · 4d ago
More
About TCMD
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.

Webull offers Tactile Systems Technology Inc stock information, including NASDAQ: TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.